Practice
Featured experience
Rent the Runway growth recapitalization
We advised Rent the Runway on the transactions
ORIX USA acquisition of majority stake in Hilco Global
We are advising ORIX Corporation USA on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
Arcadium Lithium $6.7 billion acquisition by Rio Tinto
We are advising Arcadium Lithium on the transaction
Ingersoll-Rand Luxembourg Finance S.A. $1.5 Billion Senior Notes Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC…
Davis Polk Advises S&P Global on Its Sale of SPIAS
Davis Polk is advising S&P Global Inc. on the sale of its subsidiary, Standard & Poor’s Investment Advisory Services…
Davis Polk Advises an Ad Hoc Group of Lenders in Connection with CTI Foods Restructuring
Davis Polk is advising an ad hoc group of lenders (the “Ad Hoc Group”) under a $347 million first…
Davis Polk Advises ShockWave Medical, Inc. on Its $111.4 Million Initial Public Offering
Davis Polk advised ShockWave Medical, Inc. on its SEC-registered initial public offering of 6,555,000 shares of common stock…
Mitsui Sumitomo Insurance Company, Limited $910 Million Step-Up Callable Perpetual Subordinated Notes Offering
Davis Polk advised the joint book runners in connection with a Rule 144A/Regulation S offering by Mitsui Sumitomo Insurance…
FMC completes spinoff of Livent
Davis Polk advised FMC Corporation in connection with the spinoff of its 123,000,000 shares of common stock of Livent…
Cornell Capital’s Corelle Brands to merge with Instant Brands
Davis Polk is advising Cornell Capital LLC on the merger of its portfolio company, Corelle Brands LLC, with Instant Brands,…
Davis Polk Advises Roche on Its Acquisition of Spark Therapeutics
Davis Polk is advising Roche on its approximately $4.3 billion acquisition of Spark Therapeutics, Inc. The transaction,…
Pernix Enters into an Agreement for the Sale of Substantially All of Its Assets Subject to a Competitive Bidding Process and Files for Chapter 11
Davis Polk is advising Pernix Therapeutics Holdings, Inc. in connection with its restructuring under chapter 11 of the…
Davis Polk Advises Attunity on Its Acquisition by Qlik
Davis Polk is advising Attunity Ltd. on its approximately $560 million acquisition by Qlik Technologies Inc. The transaction…